227 related articles for article (PubMed ID: 23261847)
1. Antiviral drug discovery for the treatment of enterovirus 71 infections.
Shang L; Xu M; Yin Z
Antiviral Res; 2013 Feb; 97(2):183-94. PubMed ID: 23261847
[TBL] [Abstract][Full Text] [Related]
2. Development of antiviral agents toward enterovirus 71 infection.
Pourianfar HR; Grollo L
J Microbiol Immunol Infect; 2015 Feb; 48(1):1-8. PubMed ID: 24560700
[TBL] [Abstract][Full Text] [Related]
3. Recent Progress towards Novel EV71 Anti-Therapeutics and Vaccines.
Ng Q; He F; Kwang J
Viruses; 2015 Dec; 7(12):6441-57. PubMed ID: 26670245
[TBL] [Abstract][Full Text] [Related]
4. Antiviral effects of two Ganoderma lucidum triterpenoids against enterovirus 71 infection.
Zhang W; Tao J; Yang X; Yang Z; Zhang L; Liu H; Wu K; Wu J
Biochem Biophys Res Commun; 2014 Jul; 449(3):307-12. PubMed ID: 24845570
[TBL] [Abstract][Full Text] [Related]
5. The antiviral effect of 7-hydroxyisoflavone against Enterovirus 71 in vitro.
Wang HQ; Meng S; Li ZR; Peng ZG; Han YX; Guo SS; Cui XL; Li YH; Jiang JD
J Asian Nat Prod Res; 2013; 15(4):382-9. PubMed ID: 23464760
[TBL] [Abstract][Full Text] [Related]
6. [Study on the association of hand, foot and mouth disease and enterovirus 71/CA16 among children in Beijing, 2007].
Zhu RN; Qian Y; Deng J; Xing JF; Zhao LQ; Wang F; Liao B; Ren XX; Li Y; Zhang Q; Li J
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):1004-8. PubMed ID: 18399150
[TBL] [Abstract][Full Text] [Related]
7. Apigenin inhibits enterovirus 71 replication through suppressing viral IRES activity and modulating cellular JNK pathway.
Lv X; Qiu M; Chen D; Zheng N; Jin Y; Wu Z
Antiviral Res; 2014 Sep; 109():30-41. PubMed ID: 24971492
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic features and molecular analysis of enterovirus 71 infection: report of an autopsy case from the epidemic of hand, foot and mouth disease in China.
Zhang YC; Jiang SW; Gu WZ; Hu AR; Lu CT; Liang XY; Hu YR; Zhu DD; Xie L
Pathol Int; 2012 Aug; 62(8):565-70. PubMed ID: 22827767
[TBL] [Abstract][Full Text] [Related]
9. EV71 vaccines: a first step towards multivalent hand, foot and mouth disease vaccines.
Klein MH
Expert Rev Vaccines; 2015 Mar; 14(3):337-40. PubMed ID: 25536888
[TBL] [Abstract][Full Text] [Related]
10. EV71: an emerging infectious disease vaccine target in the Far East?
Xu J; Qian Y; Wang S; Serrano JM; Li W; Huang Z; Lu S
Vaccine; 2010 Apr; 28(20):3516-21. PubMed ID: 20304038
[TBL] [Abstract][Full Text] [Related]
11. [Advances in functional studies of nonstructural proteins and development of antiviral agents for enterovirus 71].
Qin XY; Lin L; Yang Y; Zhang SX; Kong JQ; Cheng KD; Zhao YF; Wang W
Yao Xue Xue Bao; 2011 Jul; 46(7):753-61. PubMed ID: 22010343
[TBL] [Abstract][Full Text] [Related]
12. Seroepidemiology of Enterovirus 71 infection prior to the 2011 season in children in Shanghai.
Zeng M; El Khatib NF; Tu S; Ren P; Xu S; Zhu Q; Mo X; Pu D; Wang X; Altmeyer R
J Clin Virol; 2012 Apr; 53(4):285-9. PubMed ID: 22265829
[TBL] [Abstract][Full Text] [Related]
13. Antiviral activity of Paulownia tomentosa against enterovirus 71 of hand, foot, and mouth disease.
Ji P; Chen C; Hu Y; Zhan Z; Pan W; Li R; Li E; Ge HM; Yang G
Biol Pharm Bull; 2015; 38(1):1-6. PubMed ID: 25744451
[TBL] [Abstract][Full Text] [Related]
14. Salvianolic Acid B Inhibits Hand-Foot-Mouth Disease Enterovirus 71 Replication through Enhancement of AKT Signaling Pathway.
Kim SH; Lee J; Jung YL; Hong A; Nam SJ; Lim BK
J Microbiol Biotechnol; 2020 Jan; 30(1):38-43. PubMed ID: 31752055
[TBL] [Abstract][Full Text] [Related]
15. Suramin inhibits EV71 infection.
Wang Y; Qing J; Sun Y; Rao Z
Antiviral Res; 2014 Mar; 103():1-6. PubMed ID: 24374150
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of enterovirus 71 replication by an α-hydroxy-nitrile derivative NK-1.9k.
Wang Y; Cao L; Zhai Y; Ma J; Nie Q; Li T; Yin Z; Sun Y; Shang L
Antiviral Res; 2017 May; 141():91-100. PubMed ID: 28063993
[TBL] [Abstract][Full Text] [Related]
17. The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains.
Wu Y; Yeo A; Phoon MC; Tan EL; Poh CL; Quak SH; Chow VT
Int J Infect Dis; 2010 Dec; 14(12):e1076-81. PubMed ID: 20952237
[TBL] [Abstract][Full Text] [Related]
18. An enterovirus 71 epidemic in Guangdong Province of China, 2008: epidemiological, clinical, and virogenic manifestations.
Sun LM; Zheng HY; Zheng HZ; Guo X; He JF; Guan DW; Kang M; Liu Z; Ke CW; Li JS; Liu L; Guo RN; Yoshida H; Lin JY
Jpn J Infect Dis; 2011; 64(1):13-8. PubMed ID: 21266750
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of a stable eGFP enterovirus 71 for antiviral screening.
Shang B; Deng C; Ye H; Xu W; Yuan Z; Shi PY; Zhang B
Antiviral Res; 2013 Feb; 97(2):198-205. PubMed ID: 23267829
[TBL] [Abstract][Full Text] [Related]
20. Diseases caused by enterovirus 71 infection.
Lee TC; Guo HR; Su HJ; Yang YC; Chang HL; Chen KT
Pediatr Infect Dis J; 2009 Oct; 28(10):904-10. PubMed ID: 20118685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
